Tiziana Life Sciences Ltd. (NASDAQ: TLSA)
$0.81
N/A ( 0% ) 24.0K
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Market Data
Open
$0.81
Previous close
$0.81
Volume
24.0K
Market cap
$82.23M
Day range
$0.81 - $0.84
52 week range
$0.41 - $1.05
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | Jun 28, 2024 |
6-k | Quarterly Reports | 3 | Jun 26, 2024 |
6-k | Quarterly Reports | 3 | Jun 11, 2024 |
6-k | Quarterly Reports | 3 | Jun 06, 2024 |
6-k | Quarterly Reports | 3 | Jun 04, 2024 |
6-k | Quarterly Reports | 3 | May 30, 2024 |
6-k | Quarterly Reports | 3 | May 13, 2024 |
20-f | Annual reports | 108 | May 10, 2024 |
nt | Quarterly Reports | 1 | Apr 30, 2024 |
6-k | Quarterly Reports | 4 | Apr 25, 2024 |